Viewing StudyNCT00221325



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00221325
Status: COMPLETED
Last Update Posted: 2015-02-16
First Post: 2005-09-14

Brief Title: A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Conditions & Keywords Data

Conditions:
Name
Intraocular Lymphoma
Central Nervous System Lymphoma
Keywords:
Name View
Phase I Clinical Trial View
Pharmacokinetics View
Pharmacodynamics View
CNS Lymphoma View
Ocular Lymphoma View